Home
  • E-mailRolf.Bjerkvig@uib.no
  • Phone+47 55 58 63 52+47 951 18 268
  • Visitor Address
    Jonas Lies vei 91
  • Postal Address
    Postboks 7804
    5020 Bergen

Rolf Bjerkvig (f. 1953) is Professor for cell biology and has since the ealy 80s worked in experimental cancer biology.

Bjerkvig is Director of the Kristian Gerhard Jebsen Brain Tumor Research Center, located at the Department of Biomedicine. He is director of the Oncology Department at the Luxembourg Institute of Health, and has established the NORLUX Neuro-Oncology network.

Dr Bjerkvig receives major grants from the Norwegian Research Council, The Norwegian Cancer Society and the European Commission. He is on the editorial board on several international journals and is sitting in several national as well as international funding committees for cancer research in Europe. He has published more than 200 articles in scientific literature and has received a number of research prizes for his work. In 2015, Bjerkvig was awarded the King Olav V Research Prize in Cancer Research.

OD1ANA - Anatomy

MEDOD1, MEDOD2

MEIBM900

FARM260 - Molecular cell biology

BMED330 - intercellular communication

BMED331 - tumor biology

  • Sulheim, Einar; Mørch, Ýrr Asbjørg; Snipstad, Sofie; Borgos, Sven Even F.; Miletic, Hrvoje; Bjerkvig, Rolf; Davies, Catharina de Lange; Åslund, Andreas. 2019. Therapeutic effect of cabazitaxel and blood-brain barrier opening in a patient-derived glioblastoma model. Nanotheranostics. 103-112.
  • Dirkse, Anna; Golebiewska, Anna; Buder, Thomas; Nazarov, Petr V.; Muller, Arnaud; Poovathingal, Suresh K.; Brons, Nicolaas H. C.; Leite, Sonia; Sauvageot, Nicolas; Sarkisjan, Dzjemma; Seyfrid, Mathieu; Fritah, Sabrina; Stieber, Daniel; Michelucci, Alesandro; Hertel, Frank; Herold-Mende, Christel; Azuaje, Francisco; Skupin, Alexander; Bjerkvig, Rolf; Deutsch, Andreas; Voss-Böhme, Anja; Niclou, Simone Pierrette. 2019. Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. Nature Communications.
  • Säälik, Pille; Lingasamy, Prakash; Toome, Kadri; Mastandrea, Ignacio; Rousso-Noori, Liat; Tobi, Allan; Simón-Gracia, Lorena; Hunt, Hedi; Paiste, Päärn; Kotamraju, Venkata Ramana; Bergers, Gabriele; Asser, Toomas; Ratsep, Tonu; Ruoslahti, Erkki; Bjerkvig, Rolf; Friedmann-Morvinski, Dinorah; Teesalu, Tambet. 2019. Peptide-guided nanoparticles for glioblastoma targeting. Journal of Controlled Release. 109-118.
  • Biedermann, Julia; Preussler, Mathias; Conde, Marina; Peitzsch, Mirko; Richter, Susan; Wiedemuth, Ralf; Abou-El-Ardat, Khalil; Krüger, Alexander; Meinhardt, Mathias; Schackert, Gabriele; Leenders, William P.J.; Herold-Mende, Christel; Niclou, Simone Pierrette; Bjerkvig, Rolf; Eisenhofer, Graeme; Temme, Achim; Seifert, Michael; Kunz-Schughart, Leoni A.; Schröck, Evelin; Klink, Barbara. 2019. Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin. Cancers.
  • Han, Mingzhi; Wang, Shuai; Fritah, Sabrina; Wang, Xu; Zhou, Wenjing; Yang, Ning; Ni, Shilei; Huang, Bin; Chen, Anjing; Li, Gang; Miletic, Hrvoje; Thorsen, Frits; Bjerkvig, Rolf; Li, Xingang; Wang, Jian. 2019. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling. Brain.
  • Aasen, Synnøve Nymark; Parajuli, Himalaya; Hoang, Tuyen; Feng, Zichao; Stokke, Krister; Wang, Jiwei; Roy, Kislay; Bjerkvig, Rolf; Knappskog, Stian; Thorsen, Frits. 2019. Effective treatment of metastatic melanoma by combining mapk and pi3k signaling pathway inhibitors. International Journal of Molecular Sciences. 1-19.
  • Exner, Nadin D.; Valenzuela, Jaime A.C.; Abou-El-Ardat, Khalil; Miletic, Hrvoje; Huszthy, Peter Csaba; Radehaus, Petra M.; Schröck, Evelin; Bjerkvig, Rolf; Kaderali, Lars; Klink, Barbara; Nigro, Janice Marie. 2019. Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes. OncoTarget. 3641-3653.
  • Sulheim, Einar; Mørch, Ýrr Asbjørg; Snipstad, Sofie; Borgos, Sven Even F.; Miletic, Hrvoje; Bjerkvig, Rolf; Davies, Catharina de Lange; Åslund, Andreas. 2019. Blood brain barrier opening and Therapeutic Effect of Free and Nanoencapsulated Cabazitaxel in an Invasive Patient-Derived Glioblastoma Model.
  • Lingasamy, Prakash; Tobi, Allan; Haugas, Maarja; Hunt, Hedi; Paiste, Paarn; Asser, Toomas; Ratsep, Tonu; Kotamraju, Venkata Ramana; Bjerkvig, Rolf; Teesalu, Tambet. 2019. Bi-specific tenascin-C and fibronectin targeted peptide for solid tumor delivery. Biomaterials. 1-11.
  • Johannessen, Tor-Christian Aase; Bjerkvig, Rolf. 2019. A new chance for EGFR inhibition in glioblastoma? Neuro-Oncology. 1487-1488.

More information in national current research information system (CRIStin)

1987: Dr. philos. The Gade Institute of Pathology, University of Bergen
1981: M.Sc. Immunology, University of San Francisco, 1981.

Fields of competence